ALTUVIIIO
Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl
Listed by Bioverativ Therapeutics Inc.
- Form
- Kit
What it contains
No active ingredients listed in the FDA record.
FDA record
| Dosage form | Kit |
|---|---|
| Approval route | BLA — biologic licence |
| NDC code | 71104-983 |
| FDA application | BLA125771 |
| RxNorm concept | 2631088 |
| Package sizes listed | 1 |
| Marketed since | February 2023 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.